keyword
https://read.qxmd.com/read/38586124/emerging-and-upcoming-therapies-in-insomnia
#21
JOURNAL ARTICLE
Woo-Ju Kim, Ho-Sook Kim
Insomnia, commonly treated with benzodiazepine (BZD) receptor agonists, presents challenges due to associated serious side effects such as abuse and dependence. To address these concerns, many researches have been conducted to develop and advance both pharmacological and non-pharmacological interventions. Dual orexin receptor antagonists (DORAs), which include suvorexant, daridorexant and lemborexant, have recently been approved by United States Food and Drug Administration (US FDA) as a novel pharmacotherapeutic alternative...
March 2024: Translational and clinical pharmacology
https://read.qxmd.com/read/38574251/the-digital-navigator-standardizing-human-technology-support-in-app-integrated-clinical-care
#22
JOURNAL ARTICLE
Kelly Chen, Erlend Lane, James Burns, Natalia Macrynikola, Sarah Chang, John Torous
Background: Mental health apps offer scalable care, yet clinical adoption is hindered by low user engagement and integration challenges into clinic workflows. Human support staff called digital navigators, trained in mental health technology, could enhance care access and patient adherence and remove workflow burdens from clinicians. While the potential of this role is clear, training staff to become digital navigators and assessing their impact are primary challenges. Methods: We present a detailed manual/framework for implementation of the Digital Navigator within a short-term, cognitive-behavioral therapy-focused hybrid clinic...
April 4, 2024: Telemedicine Journal and E-health
https://read.qxmd.com/read/38568733/a-self-guided-web-based-app-mydiamate-for-enhancing-mental-health-in-adults-with-type-1-diabetes-insights-from-a-real-world-study-in-the-netherlands
#23
JOURNAL ARTICLE
Jiska Embaye, Maartje de Wit, Frank Snoek
BACKGROUND: MyDiaMate is a web-based intervention specifically designed for adults with type 1 diabetes (T1D) that aims to help them improve and maintain their mental health. Prior pilot-testing of MyDiaMate verified its acceptability, feasibility, and usability. OBJECTIVE: This study aimed to investigate the real-world uptake and usage of MyDiaMate in the Netherlands. METHODS: Between March 2021 and December 2022, MyDiaMate was made freely available to Dutch adults with T1D...
April 3, 2024: JMIR Diabetes
https://read.qxmd.com/read/38521133/predicting-response-to-a-smartphone-based-cognitive-behavioral-therapy-for-body-dysmorphic-disorder
#24
JOURNAL ARTICLE
Jennifer L Greenberg, Hilary Weingarden, Susanne S Hoeppner, Rebecca M Berger-Gutierrez, Dalton Klare, Ivar Snorrason, Omar Costilla-Reyes, Morgan Talbot, Katharine E Daniel, Rachel C Vanderkruik, Armando Solar-Lezama, Oliver Harrison, Sabine Wilhelm
BACKGROUND: Body dysmorphic disorder (BDD) is a severe, chronic disorder if untreated. Smartphone cognitive behavioral therapy (CBT) for BDD is efficacious and can reduce key treatment barriers (e.g., lack of clinicians, cost, stigma). While promising, little is known about who is more or less likely to benefit from this approach. METHODS: This is a secondary data analysis of a randomized, waitlist-controlled trial of smartphone CBT for BDD. Participants (N = 80) were recruited nationally and randomized to receive a 12-week, coach-guided CBT for BDD app, either immediately or after a 12-week waitlist...
March 21, 2024: Journal of Affective Disorders
https://read.qxmd.com/read/38512281/therapist-guided-versus-self-guided-cognitive-behavioral-therapy-a-systematic-review
#25
JOURNAL ARTICLE
Luísa Pelucio, Laiana A Quagliato, Antonio Egidio Nardi
Objective: To evaluate traditional versus guided cognitive-behavioral therapy (CBT) with the use of applications and technological innovations. Data Sources: A systematic search was conducted in the MEDLINE/PubMed, SciELO, and Cochrane Library databases and included randomized controlled trials (RCTs) from inception to March 30, 2023, with no language restrictions. Only RCTs with available text were included, which is valid from the app versus traditional CBT comparison perspective. The search terms were "apps" OR "app" AND "cognitive behavior therapy" OR "self-guided cognitive behavioral therapy" OR "cognitive behavior therapy" OR "CBT" OR "self-guided CBT" OR "iCBT" OR "unguided iCBT...
March 21, 2024: Primary Care Companion to CNS Disorders
https://read.qxmd.com/read/38502164/association-of-digital-engagement-with-relaxation-tools-and-stress-level-reduction-retrospective-cohort-study
#26
JOURNAL ARTICLE
Inbar Breuer-Asher, Marilyn D Ritholz, David L Horwitz, Omar Manejwala, Ephraim Behar, Yifat Fundoiano-Hershcovitz
BACKGROUND: Stress is an emotional response caused by external triggers and is a high-prevalence global problem affecting mental and physical health. Several different digital therapeutic solutions are effective for stress management. However, there is limited understanding of the association between relaxation components and stress levels when using a digital app. OBJECTIVE: This study investigated the contribution of relaxation tools to stress levels over time...
March 19, 2024: JMIR Formative Research
https://read.qxmd.com/read/38498030/preliminary-efficacy-of-a-cognitive-behavioral-therapy-based-smartphone-app-for-smoking-cessation-in-china-randomized-controlled-pilot-trial
#27
JOURNAL ARTICLE
Shanshan Chen, Jinsong Tang, Congyang Wu, Ge Zhang, Jing Zhang, Yanhui Liao
BACKGROUND: The overall prevalence of cigarette smokers in China is very high, and China's total cigarette consumption makes up more than 40% of the world's consumption. In view of the lack of smoking cessation services and social support in China and the effectiveness of mobile phone apps for quitting smoking in other countries, we carried out a smartphone app-based smoking cessation trial in China. OBJECTIVE: This study aimed to evaluate the efficacy of a cognitive behavioral therapy (CBT)-based smoking cessation smartphone app among smokers seeking treatment in China...
March 18, 2024: JMIR Formative Research
https://read.qxmd.com/read/38491775/the-use-of-mhealth-apps-to-improve-hospital-nurses-mental-health-and-well-being-a-systematic-review
#28
REVIEW
Cynthia Moore, Stephanie Kelly, Bernadette Melnyk
BACKGROUND: Nursing well-being has become a heightened focus since the COVID-19 pandemic. Nurses are leaving the profession early in their careers or retiring sooner than expected. Those who remain in the workforce report higher levels of burnout, anxiety, depression, and exhaustion. There is concern that there may be a shortage of at least half a million nurses by 2030. AIMS: This systematic review aimed to investigate the evidence of using a mental health promotion mHealth app to improve the mental health of hospital nurses...
March 15, 2024: Worldviews on Evidence-based Nursing
https://read.qxmd.com/read/38471275/reducing-brain-a%C3%AE-burden-ameliorates-high-fat-diet-induced-fatty-liver-disease-in-app-ps1-mice
#29
JOURNAL ARTICLE
Huey-Jen Tsay, Yu-Ling Gan, Yu-Han Su, Yu-Yo Sun, Heng-Hsiang Yao, Hui-Wen Chen, Ying-Ting Hsu, John Tsu-An Hsu, Horng-Dar Wang, Feng-Shiun Shie
High-fat diet (HFD)-induced fatty liver disease is a deteriorating risk factor for Alzheimer's disease (AD). Mitigating fatty liver disease has been shown to attenuate AD-like pathology in animal models. However, it remains unclear whether enhancing Aβ clearance through immunotherapy would in turn attenuate HFD-induced fatty liver or whether its efficacy would be compromised by long-term exposure to HFD. Here, the therapeutic potentials of an anti-Aβ antibody, NP106, was investigated in APP/PS1 mice by HFD feeding for 44 weeks...
March 11, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38468404/optimizing-smartphone-psychotherapy-for-depressive-symptoms-in-patients-with-cancer-multiphase-optimization-strategy-using-a-decentralized-multicenter-randomized-clinical-trial-j-support-2001-study
#30
JOURNAL ARTICLE
Tatsuo Akechi, Toshiaki A Furukawa, Hisashi Noma, Hiroji Iwata, Tatsuya Toyama, Kenji Higaki, Hiromichi Matsuoka, Sadamoto Zenda, Tsuguo Iwatani, Kazuhisa Akahane, Akira Inoue, Yasuaki Sagara, Megumi Uchida, Fuminobu Imai, Kanae Momino, Gen Imaizumi, Takuhiro Yamaguchi, Tomoe Mashiko, Tempei Miyaji, Masaru Horikoshi, Naomi Sakurai, Tatsuya Onishi, Yukihide Kanemitsu, Takeshi Murata, Yumi Wanifuchi-Endo, Hiroaki Kuroda, Ryutaro Nishikawa, Minoru Miyashita, Masakazu Abe, Yosuke Uchitomi
AIM: Patients with cancer experience various forms of psychological distress, including depressive symptoms, which can impact quality of life, elevate morbidity risk, and increase medical costs. Psychotherapy and pharmacotherapy are effective for reducing depressive symptoms among patients with cancer, but most patients prefer psychotherapy. This study aimed to develop an efficient and effective smartphone psychotherapy component to address depressive symptom. METHODS: This was a decentralized, parallel-group, multicenter, open, individually randomized, fully factorial trial...
March 11, 2024: Psychiatry and Clinical Neurosciences
https://read.qxmd.com/read/38465995/pilot-study-of-a-digital-behavioral-therapy-for-overactive-bladder-in-women
#31
JOURNAL ARTICLE
Celine Sooknarine, Sylvia Farrell, Susmita Sarma, Fadi Salameh, Naomi Burke, Brendan Staunton, Emma Carr, K Sexton, Gerry Agnew, Andrew Downey, Francis D'Arcy, Geoffrey W Cundiff
IMPORTANCE: The burden and high prevalence of overactive bladder (OAB) underline the urgent need for effective treatment. This study provides an initial look at an alternative approach to behavioral therapy for overactive bladder (OAB) that is delivered as an app on a smartphone. OBJECTIVE: This study aimed to investigate feasibility, acceptability, and preliminary efficacy of a digital therapeutic for OAB. STUDY DESIGN: This was a multicentered prospective pilot study...
March 7, 2024: Urogynecology (Phila)
https://read.qxmd.com/read/38463534/smartphone-apps-for-problem-gambling-a-review-of-content-and-quality
#32
JOURNAL ARTICLE
Li Yan McCurdy, Jennifer M Loya, Victoria R Hart-Derrick, Griffin C Young, Brian D Kiluk, Marc N Potenza
PURPOSE OF REVIEW: Problem gambling can have profound consequences for affected individuals, yet only a small proportion of people with problem gambling seek treatment. Mobile phone applications (apps) may provide an effective and scalable therapeutic option. The purpose of this study was to evaluate publicly available mobile apps aimed at improving problematic gambling behavior. RECENT FINDINGS: To date, there are no published studies that have evaluated the quality of publicly available smartphone apps for problem gambling in the US...
June 2023: Current Addiction Reports
https://read.qxmd.com/read/38461772/development-and-usability-testing-of-a-cognitive-behavioral-therapy-guided-self-help-mobile-app-and-social-media-group-for-the-post-acute-treatment-of-anorexia-nervosa
#33
JOURNAL ARTICLE
Agatha A Laboe, Claire G McGinnis, Molly Fennig, Kianna Zucker, Ellis Wu, Jillian Shah, Julie Levitan, Marie-Laure Firebaugh, Anna M Bardone-Cone, Kathleen M Pike, C Barr Taylor, Denise E Wilfley, Ellen E Fitzsimmons-Craft
OBJECTIVE: Anorexia nervosa (AN) is often treated in the acute setting, but relapse after treatment is common. Cognitive-behavioral therapy (CBT) is useful in the post-acute period, but access to trained providers is limited. Social support is also critical during this period. This study utilized a user-centered design approach to develop and evaluate the usability of a CBT-based mobile app and social networking component for post-acute AN support. METHOD: Participants (N = 19) were recently discharged from acute treatment for AN...
March 7, 2024: Eating Behaviors
https://read.qxmd.com/read/38419096/an-e-mental-health-intervention-to-reduce-depression-symptoms-in-individuals-with-obesity-study-protocol-for-the-randomized-controlled-two-armed-confirmatory-lightmood-trial
#34
JOURNAL ARTICLE
Dilara Kocol, Sheila Geiger, Adam Schweda, Jil Beckord, Theresa Schadendorf, Christoph Jansen, Anita Robitzsch, Eva-Maria Skoda, Martin Teufel, Alexander Bäuerle
BACKGROUND: Patients with obesity often experience psychological distress, specifically depression symptoms. Due to various barriers, such as limitations of healthcare offers, digital interventions, for example medical apps, can provide a suitable approach to support affected people. In the envisaged prospective randomized controlled trial, we aim to examine the efficacy of the LightMood intervention. The LightMood intervention is a manualized and user-centered, digital intervention for patients with obesity, with a duration of 4 months, which contains elements of cognitive behavioral therapy and mindfulness-based and skills-based exercises...
February 28, 2024: Trials
https://read.qxmd.com/read/38418036/symptom-reduction-and-engagement-in-a-cognitive-behavioral-mobile-phone-app-a-study-of-user-profiling-to-determine-prognostic-indicators
#35
JOURNAL ARTICLE
Danilo Moggia, Wolfgang Lutz, Nikolaos Kazantzis, Brian Schwartz, David Bakker
OBJECTIVE: We investigated the presence of latent transition profiles in a sample of users of a cognitive-behavioral mental health app for the general population. Users' baseline characteristics were used as predictors of the profiles. The role of engagement with the app in the transition profiles was examined. METHOD: A total of 541 users completed the Patient Health Questionnaire-9 and the General Anxiety Disorder-7 when started using the app and 30 days after...
March 2024: Behavior Therapy
https://read.qxmd.com/read/38369275/inhibition-of-alzheimer-s-disease-by-4-octyl-itaconate-revealed-by-rna-seq-transcriptome-analysis
#36
JOURNAL ARTICLE
Yingchao Liu, Pengcheng Xia, Shuai Zong, Ni Zheng, Xiaolin Cui, Cuicui Wang, Miaomiao Wang, Xueying Wang, Shuyi Yu, Hao Zhao, Zhiming Lu
AIMS: This study aimed to examine the therapeutic effects and response mechanisms of 4-OI in Alzheimer's disease (AD). METHODS: In this study, network pharmacology was employed to analyze potential targets for AD drug therapy. Immunofluorescence and quantitative reverse transcription polymerase chain reaction (qRT-PCR) techniques were utilized to detect inflammatory phenotypes in a 4-OI-resistant mouse microglia cell line (BV2). We conducted four classical behavioral experiments, namely the open field test, new object recognition test, Y maze test, and Morris water maze, to assess the emotional state and cognitive level of APPswe/PS1dE9 (referred to as APP/PS1) mice after 4-OI treatment...
February 16, 2024: European Journal of Pharmacology
https://read.qxmd.com/read/38366975/pain-coping-multidisciplinary-care-and-mhealth-patients-views-on-managing-advanced-cancer-pain
#37
JOURNAL ARTICLE
Sara M DeForge, Kyla Smith, Kris-Ann Anderson, Ashton R Baltazar, Meghan Beck, Andrea C Enzinger, James A Tulsky, Matthew Allsop, Robert R Edwards, Kristin L Schreiber, Desiree R Azizoddin
OBJECTIVE: Pain is common among people with advanced cancer. While opioids provide significant relief, incorporating psycho-behavioral treatments may improve pain outcomes. We examined patients' experiences with pain self-management and how their self-management of chronic, cancer-related pain may be complemented by behavioral mobile health (mHealth) interventions. METHODS: We conducted semi-structured qualitative interviews with patients with advanced cancer and pain...
February 2024: Psycho-oncology
https://read.qxmd.com/read/38352466/adaptations-of-an-online-cognitive-behavioral-therapy-intervention-for-binge-purge-type-eating-disorders-in-publicly-insured-and-uninsured-adults-a-pilot-study
#38
Siena S Vendlinski, Agatha A Laboe, Peyton Crest, Claire G McGinnis, Molly Fennig, Denise E Wilfley, C Barr Taylor, Ellen E Fitzsimmons-Craft, Erin C Accurso
Background Publicly-insured and uninsured individuals-many of whom are marginalized because of race/ethnicity, disability and/or sexual preferences-experience barriers to accessing evidence-based interventions for eating disorders (EDs). Additionally, EBIs have not been developed with or for diverse populations, exacerbating poor treatment uptake. Mobile technology is perfectly positioned to bridge this gap and increase access to low-cost, culturally-sensitive EBIs. Methods This study leverages a user-centered design approach to adapt an existing coached cognitive-behavioral therapy-based digital program and evaluate its usability in a sample of 11 participants with (sub)clinical binge-purge type EDs who are publicly-insured ( n  = 10) or uninsured ( n  = 1)...
February 2, 2024: Research Square
https://read.qxmd.com/read/38329869/modulatory-effect-of-low-intensity-transcranial-ultrasound-stimulation-on-behaviour-and-neural-oscillation-in-mouse-models-of-alzheimer-s-disease
#39
JOURNAL ARTICLE
Huifang Yang, Jiaqing Yan, Hui Ji, Mengran Wang, Teng Wang, Huiling Yi, Lanxiang Liu, Xin Li, Yi Yuan
Transcranial ultrasound stimulation (TUS) is a noninvasive brain neuromodulation technique. The application of TUS for Alzheimer's disease (AD) therapy has not been widely studied. In this study, a long-term course (28 days) of TUS was used to stimulate the hippocampus of APP/PS1 mice. We examined the modulatory effect of TUS on behavior and neural oscillation in AD mice. We found that TUS can 1) improve the learning and memory abilities of AD mice; 2) reduce the phase-amplitude coupling of delta-epsilon, delta-gamma and theta-gamma frequency bands of local field potential, and increase the relative power of epsilon frequency bands in AD mice; 3) reduce the spike firing rate of interneurons and inhibit the phase-locked angle deflection between the theta frequency bands and the spikes of the two types of neurons that develops with the progression of the disease in AD mice...
2024: IEEE Transactions on Neural Systems and Rehabilitation Engineering
https://read.qxmd.com/read/38327209/design-synthesis-and-biological-investigation-of-quinazoline-derivatives-as-multitargeting-therapeutics-in-alzheimer-s-disease-therapy
#40
JOURNAL ARTICLE
Akash Verma, Digambar Kumar Waiker, Neha Singh, Anima Roy, Namrata Singh, Poorvi Saraf, Bhagwati Bhardwaj, Sairam Krishnamurthy, Surendra Kumar Trigun, Sushant Kumar Shrivastava
An efficient and promising method of treating complex neurodegenerative diseases like Alzheimer's disease (AD) is the multitarget-directed approach. Here in this work, a series of quinazoline derivatives ( AV-1 to AV-21 ) were rationally designed, synthesized, and biologically evaluated as multitargeted directed ligands against human cholinesterase (hChE) and human β-secretase (hBACE-1) that exhibit moderate to good inhibitory effects. Compounds AV-1 , AV-2 , and AV-3 from the series demonstrated balanced and significant inhibition against these targets...
February 8, 2024: ACS Chemical Neuroscience
keyword
keyword
69880
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.